The following are some of the U.S. FDA’s actions taken, as of April 2, in its ongoing response effort to the COVID-19 pandemic: FDA-ARGOS SARS-CoV-2 Reference Grade Sequence Data Now Available: The FDA—in collaboration with the CDC, the Biodefense and Emerging Infections Research Resources Repository (BEI Resources) and the Institute for Genome Sciences at the University of Maryland and the National Center for Biotechnology Information (NCBI)—developed quality-controlled, reference seque...